英国初级保健机构糖尿病患者肾脏并发症管理的移动临床决策支持系统:卡塔尔世界杯8强波胆分析混合方法可行性研究%A Alhodaib,Hala Ibrahim %A Antza,Christina %A Chandan,Joht Singh %A Hanif,Wasim %A Sankaranarayanan,Sailesh %A Paul,Sunjay %A Sutcliffe,Paul %A Nirantharakumar,Krishnarajah %+华威医学院健康科学部，华威大学，英国考文try, CV4 7AL, 44 2476 574505，P.A.Sutcliffe@warwick.ac.uk %K eHealth %K临床决策支持应用%K糖尿病%K慢性肾脏疾病%K可行性研究%D 2020 %7 18.11.2020 %9原始论文%J JMIR糖尿病%G英文%X背景:尝试在糖尿病(DM)管理中使用eHealth已显示出有希望的结果，主要针对患者;然而，为卫生保健提供者设计的解决方案很少。目的:本研究的目的是开展一个可行性项目，开发和评估一个移动临床决策支持系统(CDSS)工具，专门为医疗保健提供者管理糖尿病患者的慢性肾脏疾病(CKD)。方法:设计过程基于以用户为中心的设计框架的3个关键阶段。首先，通过探索性质的研究，收集糖尿病专科护士在临床实践中使用移动应用程序的经验和观点。其次，CDSS工具被开发用于糖尿病和CKD患者的管理。最后，一项随机对照试验检查了该工具的可接受性和影响。结果:我们采访了15名糖尿病专科护士。糖尿病专科护士目前在临床实践中没有使用电子健康解决方案，而大多数护士甚至不知道现有的医疗应用程序。 However, they appreciated the potential benefits that apps may bring to their clinical practice. Taking into consideration the needs and preferences of end users, a new mobile CDSS app, “Diabetes & CKD,” was developed based on guidelines. We recruited 39 junior foundation year 1 doctors (44% male) to evaluate the app. Of them, 44% (17/39) were allocated to the intervention group, and 56% (22/39) were allocated to the control group. There was no significant difference in scores (maximum score=13) assessing the management decisions between the app and paper-based version of the app’s algorithm (intervention group: mean 7.24 points, SD 2.46 points; control group: mean 7.39, SD 2.56; t37=–0.19, P=.85). However, 82% (14/17) of the participants were satisfied with using the app. Conclusions: The findings will guide the design of future CDSS apps for the management of DM, aiming to help health care providers with a personalized approach depending on patients’ comorbidities, specifically CKD, in accordance with guidelines. %M 33206055 %R 10.2196/19650 %U https://diabetes.www.mybigtv.com/2020/4/e19650 %U https://doi.org/10.2196/19650 %U http://www.ncbi.nlm.nih.gov/pubmed/33206055